Why ‘COVID 2025’ is trending in US

‘COVID 2025’ is trending across the US as Americans react to a major shift in COVID-19 vaccine policy by the Food and Drug Administration (FDA).

This fall, the FDA plans to limit vaccine access to people over 65 and those with certain medical conditions. Healthy adults under 65 may be excluded unless new trials show strong evidence of continued benefits.

This marks a big change from previous recommendations, which advised annual shots for everyone aged six months and older.

Now, the agency is moving toward a “risk-based” strategy, similar to those used in other high-income countries.

Dr. Vinay Prasad, head of the FDA’s vaccine division, and Dr. Martin Makary, the agency’s commissioner, defended the change in The New England Journal of Medicine.

“The F.D.A. will approve vaccines for high-risk persons and, at the same time, demand robust, gold-standard data on persons at low risk,” they wrote.

In a town hall, Prasad called the new policy “a reasonable compromise,” balancing access with the need for stronger evidence.

But critics warn the move could limit protection for many Americans.

“This is overly restrictive and will deny many people who want to be vaccinated a vaccine,” said Dr. Anna Durbin of Johns Hopkins University.

Dr. Daniel Griffin, a New York physician, added, “Changes like this will lead to more unnecessary deaths.”

Others worry that requiring new placebo-based trials could delay vaccine access and complicate insurance coverage.

“What they’re really doing is they’re very slowly reducing vaccination in the country,” Griffin said.

The policy change comes as COVID continues to cause hundreds of deaths per week, mostly among older adults. Still, younger people with high-risk jobs or health concerns may now find it harder to qualify for vaccines.

Some of the backlash also stems from the political backdrop.

Health Secretary Robert F. Kennedy Jr., a longtime vaccine skeptic, has questioned the safety of COVID shots and proposed placebo testing for all new vaccines.

He has also promoted alternative remedies like cod liver oil, drawing sharp criticism from public health experts.

Recently, the FDA also limited use of the Novavax vaccine to high-risk individuals, sparking further concerns.

Durbin said, “I think this is setting a dangerous precedent. It does seem to be based more on this administration’s hostility to vaccines.”

FDA officials say current lab data still show that vaccines protect those most vulnerable.

Prasad and Makary estimate that about one-third of Americans—with conditions like asthma, diabetes, depression, or pregnancy—will still qualify under the new rules.

“At-risk Americans can be reassured that they will be covered by such approvals,” Prasad said.

As the fall vaccine season nears, many Americans are unsure what to expect. With access tightening, “COVID 2025” has become a flashpoint for debate over how the nation should handle the next phase of the pandemic.

(New York Times)

ALSO READ TOP STORIES FROM NIGERIAN TRIBUNE